Laura G. Eichorn
Founder en IMAGO BIOSCIENCES, INC. .
Perfil
Laura G.
Eichorn is the founder and currently serves as the Chief Financial Officer at Imago BioSciences, Inc., a company she founded in 2012.
She previously worked as the Vice President-Operations & Finance at FerroKin BioSciences, Inc. Ms. Eichorn obtained her undergraduate degree from Frostburg State University.
Cargos activos de Laura G. Eichorn
| Empresas | Cargo | Inicio |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Founder | 01/03/2012 |
Antiguos cargos conocidos de Laura G. Eichorn.
| Empresas | Cargo | Fin |
|---|---|---|
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Director of Finance/CFO | - |
Formación de Laura G. Eichorn.
| Frostburg State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Laura G. Eichorn
